protects neurons from oxidative stress-induced cell death in vitro.
Biochem Biophys Res Comm 216:473–482.
Bonuccelli U, Nuti A, Maremmani C, Ceravolo R, Muratorio A (1992)
Steroid therapy in Huntington's disease. Adv Biochem Psychopharmacol 47:149 –154.
Brown ES, Khan DA, Nejtek VA (1999a) The psychiatric side effects of
corticosteroids. Ann Allergy Asthma Immunol 83:495 504..
Brown ES, Rush AJ, McEwen BS (1999b) Hippocampal remodeling
and damage by corticosteroids: implications for mood disorders.
Neuropsychopharmacology 21:474 484.
Carranza-Lira S, Valentino-Figueroa ML (1999) Estrogen therapy for
depression in postmenopausal women. Int J Gynecol Obstet 65:
35–38.
Chen J, Adachi N, Liu K, Arai T (1998) The effects of 17-estradiol on
ischemia-induced neuronal damage in the gerbil hippocampus.
Neuroscience 87:817–822.
Disshon KA, Dluzen DE (2000) Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP in female, but not
male rats. Brain Res 868:95–104.
Dluzen D, McDermott JL, Binjun L (1996) Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. Neurotoxicol Teratol 18:603–606.
Dooley P, Corbett D (1998) Competing processes of cell death and
recovery of function following ischemic preconditioning. Brain Res
794:119 –126.
Drevets WC (2001) Neuroimaging and neuropathological studies of
depression: implications for the cognitive-emotional features of
mood disorders. Curr Opin Neurobiol 11:240 –249.
Duen~ as M, Torres-Aleman I, Naftolin F, Garcia-Segura LM (1996)
Interaction of insulin-like growth factor-I and estradiol signaling
pathways on hypothalamic neuronal differentiation. Neuroscience
74:531–539.
Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM (1999)
Estradiol modulates bcl-2 in cerebral ischemia: a potential role for
estrogen receptors. J Neurosci 19:6385–6393.
Duman RS (1998) Novel therapeutic approaches beyond the serotonin
receptor. Biol Psychiatry 44:324 –353.
Folkerts MM, Berman RF, Muizelaar JP, Rafols JA (1998) Disruption
of MAP-2 immunostaining in rat hippocampus after traumatic brain
injury. J Neurotrauma 15:349 –363.
Friedman L, Findling RL, Buck J, Cola DM, Swales TP, Kenny JT,
Schulz SC (1996) Structural MRI and neuropsychological assessments in adolescent patients with either schizophrenia or affective
disorders. Schizophr Res 18:189 –190.
Garcia-Segura LM, Azcoitia I, DonCarlos LL (2001) Neuroprotection
by estradiol. Prog Neurobiol 63:29 –60.
Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison
RE, Hutchison JB (1999) Aromatase expression by astrocytes after
brain injury: implications for local estrogen formation in brain repair.
Neuroscience 89:567–578.
Garnier M, Di Lorenzo D, Albertini A, Maggi A (1997) Identification of
estrogen-responsive genes in neuroblastoma SK-ER3 cells. J Neurosci 17:4591–4599.
Gollapudi L, Oblinger MM (1999) Estrogen and NGF synergistically
protect terminally differentiated, ERalpha-transfected PC12 cells
from apoptosis. J Neurosci Res 56:471–481.
Green PS, Simpkins JW (2000) Neuroprotective effects of estrogens:
potential mechanisms of action. Int J Dev Neurosci 18:347–358.
Gregoire AJP, Kumar R, Everitt B, Henderson AF, Studd JWW (1996)
Transdermal oestrogen for treatment of severe postnatal depression. Int J Gynecol Obstetr 55:88.
Gridley KE, Green PS, Simpkins JW (1997) Low concentrations of
estradiol reduce -amyloid (25–35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma
cells. Brain Res 778:158 –165.
Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V,
Rangnekar VM, Mattson MP (1998) Par-4 is a mediator of neuronal
